Organ crosstalk: The role of the kidney

Current Opinion in Critical Care

Volumn 15, Issue 6, 2009, Pages 481-487

  Li, Xiang ^a   Hassoun, Heitham T ^b   Santora, Rachel ^b   Rabb, Hamid ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Acute kidney injury; Distant organ injury; Inflammation; Ischemia reperfusion

Indexed keywords

CHEMOKINE; CYTOKINE; REACTIVE OXYGEN METABOLITE;

BRAIN DYSFUNCTION; CELL DEATH; CRITICALLY ILL PATIENT; HEART DISEASE; HUMAN; INTENSIVE CARE UNIT; KIDNEY INJURY; LEUKOCYTE ACTIVATION; LIVER DYSFUNCTION; LUNG DISEASE; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; OXIDATIVE STRESS; REVIEW;

HUMANS; INFLAMMATION; ISCHEMIA; KIDNEY FAILURE, ACUTE; MULTIPLE ORGAN FAILURE;

EID: 74949129838     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e328332f69e     Document Type: Review

References (78)

1. Star RA. Treatment of acute renal failure. Kidney Int 1998; 54:1817-1831.
2. Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a mulnational, multicenter study. JAMA 2005; 294:813-818.
3. Kelly KJ, Molitoris BA. Acute renal failure in the new millennium: Time to consider combination therapy. Semin Nephrol 2000; 20:4-19.
4. Mehta RL, PascualMT, Gruta CG, et al. Refining predictive models in critically ill patients with acute renal failure. J Am Soc Nephrol 2002; 13:1350-1357.
5. Kuiper JW, Groeneveld AB, Slutsky AS, Plotz FB. Mechanical ventilation and acute renal failure. Crit Care Med 2005; 353:2788-2796.
6. Kramer AA, Postler G, Salhab KF, et al. Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability. Kidney Int 1999; 55:2362-2367.
7. Hassoun HT, Grigoryev DN, Lie ML, et al. Ischemic acute kidney injury induces a distant organ functional and genomic response distinguishable from bilateral nephrectomy. Am J Physiol Renal Physiol 2007; 293:F30-F40.
8. Rabb H, Wang Z, Zemoto T, et al. Acute renal failure leads to dysregulation of lung salt and water channels. Kidney Int 2003; 63:600-606.
9. Deng J, Hu X, Yuen PS, Star RA. Alpha-melanocyte-stimulating hormone inhibits lung injury after renal ischemia/reperfusion. Am J Respir Crit Care Med 2004; 169:749-756.
10. Klein CL, Hoke TS, Fang WF, et al. Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomy. Kidney Int 2008; 74:849-851.
11. Kim do J, Park SH, Sheen MR, et al. Comparison of experimental lung injury from acute renal failure with injury due to sepsis. Respiration 2006; 73:815-824.
12. Lemay S, Rabb H, Postler G, et al. Prominent and sustained up-regulation of gp130-signaling cytokines and the chemokine MIP-2 in murine renal ischemia-reperfusion injury. Transplantation 2000; 69:959-963.
13. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365:1231-1238.
14. Feltes CM, Van Eyk J, Rabb H. Distant-organ changes after acute kidney injury. Nephron Phys 2008; 109:80-84.
15. Grigoryev DN, Liu M, Hassoun HT, et al. The local and systemic inflammatory transcriptome after acute kidney injury. J Am Soc Nephrol 2008; 19:547-558.
16. Hoke TS, Douglas IS, Klein CL, et al. Acute renal failure after bilateral nephrectomy is associated with cytokine-mediated pulmonary injury. J Am Soc Nephrol 2007; 18:155-164.
17. Tracz MJ, Juncos JP, Croatt AJ, et al. Deficiency of heme oxygenase-1 impairs renal hemodynamics and exaggerates systemic inflammatory responses to renal ischemia. Kidney Int 2007; 72:1073-1080.
18. Fine A, Janssen-Heininger Y, Soultanakis RP, et al. Apoptosis in lung pathophysiology. Am J Physiol Lung Cell Mol Physiol 2000; 279:L423-L427.
19. Matute-Bello G, Liles WC, Radella F, et al. Neutrophil apoptosis in the acute respiratory distress syndrome. Am J Resp Crit Care Med 1997; 156:1969-1977.
20. Rafi AQ, Zeytun A, Bradley MJ, et al. Evidence for the involvement of Fas ligand and perforin in the induction of vascular leak syndrome. J Immunol 1998; 161:3077-3086.
21. Matute-Bello G, Liles WC, Steinberg KP, et al. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol 1999; 163:2217-2225.
22. Blake P, Hasegawa Y, Khosla MC, et al. Isolation of 'myocardial depressant factor(s)' from the ultrafiltrate of heart failure patients with acute renal failure. ASAIO J 1996; 42:M911-M915.
23. Kelly KJ. Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol 2003; 14:1549-1558.
24. Kuhar CG, Budihna MV, Pleskovic RZ. Mibefraduil is more effective than verapamil for restoring postischemic function of isolated hearts of guinea pigs with acute renal failure. Eur J Pharmacol 2004; 488:137-146.
25. Singh D, Chopra K. Evidence of the role of angiotensin AT (1) receptors in remote renal preconditioning of myocardium. Methods Find Exp Clin Pharmacol 2004; 26:117-122.
26. Forman MB, Virmani R, Puett DW. Mechanisms and therapy of myocardial reperfusion injury. Circulation 1990; 81:IV69-IV78.
27. Ma X-L, Lefer DJ, Lefer AM, Rothlein R. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation 1992; 86:937-946.
28. Simpson PJ, Todd RF, Fantone JC. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo-1 and anti-CD11b) that inhibits leukocyte adhesion. J Clin Invest 1988; 81:624-629.
29. Weyrich AS, Ma X-L, Lefer DJ, et al. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest 1993; 91:2620-2639.
30. Givertz MM, Colucci WS. New targets for heart-failure therapy: endothelin, inflammatory cytokines, and oxidative stress. Lancet 1998; 352 (Suppl 1):S134-S138.
31. Kapadia SR. Cytokines and heart failure. Cardiol Rev 1999; 7:196-206.
32. Bryant D, Becker L, Richardson J, et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 1998; 97:1375-1381.
33. Anker SD, Coats AJ. How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH. Int J Cardiol 2002; 86:123-130.
34. Momii H, Shimokawa H, Oyama J, et al. Inhibition of adhesion molecules markedly ameliorates cytokine-induced sustained myocardial dysfunction in dogs in vivo. J Mol Cell Cardiol 1998; 30:2637-2650. (Pubitemid 29017504)
35. Daemen MA, van 't Veer C, Denecker G, et al. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 1999; 104:541-549.
36. Fliss H, Grattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996; 79:949-956.
37. Kajstura J, Cheng W, Reiss K, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996; 74:86-107.
38. Zhao ZQ, Nakamura M, Wang NP, et al. Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res 2000; 45:651-660.
39. Wencker D, Chandra M, Nguyen K, et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 2003; 111:1497-1504.
40. MacLellan WR. Advances in the molecular mechanisms of heart failure. Curr Opin Cardiol 2000; 15:128-135.
41. Kolcio R, Rogers J, Shaw A. Organ cross talk in the critically ill: the heart and kidney. Blood Purif 2009; 27:311-320.
42. Roncho C, Happio M, House A, et al. Cardiorenal syndrome. J Am Coll Cardiol 2008; 52:1527-1539.
43. Bongartz LG, Cramer MJ, Doevendans PA, et al. The severe cardiorenal syndrome: 'guyton revisted'. Eur Heart J 2005; 26:11-17.
44. Tsagalis G, Zerefos S, Zerefos N. Cardiorenal syndrome at different stages of chronic kidney disease. Int J Artif Organs 2007; 30:564-576.
45. Burn DJ, Bates D. Neurology and the kidney. Neurol Neurosurg Psychiatry 1998; 65:810-821.
46. Liu Manchang, Liang Yideng, Chigurupati Srinivasulu, et al. Acute kidney injury leads to brain inflammation and functional changes. J Am Soc Nephrol 2008; 19:1360-1370.
47. Nguyen DN, Spapen H, Su F, et al. Elevated serum levels of S-100 beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock. Crit Care Med 2006; 34:1967-1974.
48. Kielian T, Barry B, Hickey WF. CXC chemokine receptor-2 ligands are required for neutrophil-mediated host defense in experimental brain abscesses. J Immuno 2001; 166:4634-4643.
49. Zwijnenburg PJ, Polfliet MM, Florquin S, et al. van CXC-chemokines KC and macrophage inflammatory protein-2 (MIP-2) synergistically induce leukocyte recruitment to the central nervous system in rats. Immunol Lett 2003; 85:1-4.
50. Hasselblatt M, Jeibmann A, Riesmeier B, et al. Granulocyte-colony stimulating factor (G-CSF) and G-CSF receptor expression in human ischemic stroke. Acta Neuropathol 2007; 113:45-51.
51. McColl BW, Rothwell NJ, Allan SM. Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1-and neutrophil-dependent mechanisms. J Neurosci 2007; 27:4403-4412.
52. Sehara Y, Hayashi T, Deguchi K, et al. Decreased focal inflammatory response by G-CSF may improve stroke outcome after transient middle cerebral artery occlusion in rats. J Neurosci Res 2007; 85:2167-2174.
53. Arieff Ai, Massry SG, Barrientos A, Kleeman CR. Brain water and electrolyte metabolism in uremia: effects of slow and rapid hemodialysis. Kidney Int 1973; 4:177-187.
54. Arieff Ai, Massry SG. Calcium metabolism of brain in acute renal failure: effects of uremia, hemodialysis, and parathyroid hormone. J Clin Invest 1974; 53:387-392.
55. De Deyn PP, Vanholder R, D'Hooge R. Nitric oxide in uremia: effects of several potentially toxic guanidino compounds. Kidney Int Suppl 2003; 84:S25-S28.
56. Sural S, Sharma RK, Gupta A, et al. Acute renal failure associated with liver disease in India: etiology and outcome. Ren Fail 2000; 22:623-634.
57. Golab F, Kadkhodaee M, Zahmatkesh M, et al. Ischemic and nonischemic acute kidney injury cause hepatic damage. Kidney Int 2009; 75:783-792.
58. Serteser M, Koken T, Kahraman A, et al. Changes in hepatic TNF-alpha levels, antioxidant status, and oxidation products after renal ischemia/reperfusion injury in mice. J Surg Res 2002; 107:234-240.
59. Hori O, Matsumoto M, Kuwabara K, et al. Exposure of astrocytes to hypoxia/ reoxygenation enhances expression of glucose-regulated protein 78 facilitating astrocyte release of the neuroprotective cytokine interleukin 6. J Neurochem 1996; 66:973-979.
60. Kaden J, Priesterjahn R. Increasing urinary IL-6 levels announce kidney graft rejection. Transpl Int 2000; 13 (Suppl 1):S34-S41.
61. Deng J, Kohda Y, Chiao H, et al. Interleukin-10 inhibits ischemic and cisplatininduced acute renal injury. Kidney Int 2001; 60:2118-2128.
62. Daemen MA, van de Ven MW, Heineman E, Buurman WA. Involvement of endogenous interleukin-10 and tumor necrosis factor-alpha in renal ischemiareperfusion injury. Transplantation 1999; 67:792-800.
63. Fadillioglu E, Kurcer Z, Parlakpinar H, et al. Melatonin treatment against remote organ injury induced by renal ischemia reperfusion injury in diabetes mellitus. Arch PharmRes 2008; 31:705-712.
64. Yoon JH, Gores GJ. Death receptor-mediated apoptosis and the liver. J Hepatol 2002; 37:400-410.
65. Galle PR, Hofmann WJ, Walczak H, et al. Involvement of the CD95 (APO-1/ Fas) receptor and ligand in liver damage. J Exp Med 1995; 182:1223-1230.
66. Benedetti A, Marucci L. The significance of apoptosis in the liver. Liver 1999; 19:453-463.
67. Ogasawara J, Watanabe-Fukunaga R, Adachi M, et al. Lethal effect of the anti-Fas antibody in mice. Nature 1993; 364:806-809.
68. Patel T, Roberts LR, Jones BA, Gores GJ. Dysregulation of apoptosis as a mechanism of liver disease: an overview. Semin Liver Dis 1998; 18:105-114.
69. Canbay A, Friedman S, Gores GJ. Apoptosis: the nexus of liver injury and fibrosis. Hepatology 2004; 39:273-278.
70. Lawson JA, Fisher MA, Simmons CA, et al. Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin and Fasantibody-induced liver injury. Hepatology 1998; 28:761-767.
71. Jaeschke H. Inflammation in response to hepatocellular apoptosis. Hepatology 2002; 35:964-966.
72. Faouzi S, Burckhardt BE, Hanson JC, et al. Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway. J Biol Chem 2001; 276:49077-49082.
73. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104:487-501.
74. Wallach D, Varfolomeev EE, Malinin NL, et al. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 1999; 17:331-367.
75. Paik YH, Schwabe RF, Bataller R, et al. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 2003; 37:1043-1055.
76. Slack AJ, Wendon J. The liver and the kidney in critically ill patients. Blood Purif 2009; 28:124-134.
77. Dahger L, Moore K. The hepatorenal syndrome. Gut 2001; 429:729-737.
78. Islas-Carbajal MC, Covarrubias A, Grijalva G, et al. Nitric oxide synthases inhibition results in renal failure improvement in cirrhotic rats. Live Int 2005; 25:131-140.